In 2012, the drugmaker’s profit reached RON21.03 million.
The company’s sales were at RON117.57 million (EUR26.6 million), up 12% from RON104.94 million in the previous year.
Biofarm is listed on the Bucharest stock exchange, and its shareholding structure includes SIF Muntenia (SIF4.RO), with almost 33% of the shares, SIF Banat-Crisana (SIF1.RO), with 21.3%, and SIF Moldova (SIF2.RO), with 13.8%.
Biofarm shares closed at RON0.2815 Friday, down 0.53% on the day. (EUR1=RON4.4813)